Praxis Precision Medicines, Inc. (PRAX)
Praxis Precision Medicines, Inc. (PRAX) is a Healthcare stock tracked by StreetAlpha. PRAX reports earnings on Mon, Nov 9, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (4 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 3 whale options trades in PRAX, 67% of them bullish and 33% bearish. In the past 30 days there were 6 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 6 | BTIG | Target raised | Buy | — |
| Aug 21 | Goldman Sachs | Target raised | Buy | — |
| Aug 7 | RBC Capital | Target raised | Buy | — |
| Aug 7 | Wells Fargo | Maintained | Hold | — |
| Aug 6 | Needham | Target raised | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRAX is in one of them and how their past PRAX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered PRAX in an article yet. Here's the latest on the wider market.
PRAX Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Sep 29, 2026 | Oct 13, 2026 | 14 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Jul 30, 2026 | Sep 4, 2026 | 36 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.